Kynamro

The objective of a study was to evaluate the efficacy and safety of extended dosing with Mipomersen ( Kynamro )...


Homozygous familial hypercholesterolaemia ( HoFH ) is a rare life-threatening condition characterized by markedly elevated circulating levels of low-density lipoprotein...


By inhibiting apolipoprotein B ( ApoB ) synthesis, Mipomersen ( Kynamro ) can significantly reduce ApoB-containing lipoproteins in hypercholesterolemic patients. The...


On 13 December 2012, the Committee for Medicinal Products for Human Use ( CHMP ) has adopted a negative opinion,...


The FDA ( Food and Drug Administration ) has approved Kynamro ( Mipomersen sodium ) injection as an addition to...